Table of Content

1. Introduction


2. Research Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. Global Cancer Immunotherapy Market


6. Market Share Analysis – Global Cancer Immunotherapy Market

6.1 By Products
6.2 By Application
6.3 By End User
6.4 By Countries


7. Products – Global Cancer Immunotherapy Market

7.1 Monoclonal Antibodies
7.2 Immunomodulators
7.3 Cancer Vaccines


8. Application – Global Cancer Immunotherapy Market

8.1 Lung Cancer
8.2 Breast Cancer
8.3 Colorectal Cancer
8.4 Melanoma
8.5 Prostate Cancer
8.6 Head & Neck Cancer
8.7 Others


9. End Users – Global Cancer Immunotherapy Market

9.1 Hospital
9.2 Cancer Research Center
9.3 Clinics


10. Countries – Global Cancer Immunotherapy Market

10.1 North America

10.1.1 United States
10.1.2 Canada

10.2 Europe

10.2.1 Germany
10.2.2 United Kingdom
10.2.3 France
10.2.4 Italy
10.2.5 Spain
10.2.6 Switzerland

10.3 Asia Pacific

10.3.1 Japan
10.3.2 China
10.3.3 India
10.3.4 Australia
10.3.5 South Korea
10.3.6 Indonesia

10.4 Latin America

10.4.1 Brazil
10.4.2 Argentina
10.4.3 Mexico

10.5 Middle East & Africa

10.5.1 Saudi Arabia
10.5.2 United Arab Emirates
10.5.3 South Africa

10.6 Rest of World


11. Porter’s Five Forces Analysis – Global Cancer Immunotherapy Market

11.1 Bargaining Power of Buyers
11.2 Bargaining Power of Suppliers
11.3 Degree of Rivalry
11.4 Threat of New Entrants
11.5 Threat of Substitutes


12. SWOT Analysis – Global Cancer Immunotherapy Market

12.1 Strength
12.2 Weakness
12.3 Opportunity
12.4 Threat


13. Key Players

13.1 Amgen Inc.

13.1.1 Overview
13.1.2 Recent Development
13.1.3 Revenue

13.2 AstraZeneca

13.2.1 Overview
13.2.2 Recent Development
13.2.3 Revenue

13.3 Bayer AG

13.3.1 Overview
13.3.2 Recent Development
13.3.3 Revenue

13.4 Bristol-Myers Squibb Comapny

13.4.1 Overview
13.4.2 Recent Development
13.4.3 Revenue

13.5 Pfizer Inc

13.5.1 Overview
13.5.2 Recent Development
13.5.3 Revenue

13.6 Novarts AG

13.6.1 Overview
13.6.2 Recent Development
13.6.3 Revenue

13.7 Johnson & Johnson

13.7.1 Overview
13.7.2 Recent Development
13.7.3 Revenue

13.8 Eli Lily Comapny

13.8.1 Overview
13.8.2 Recent Development
13.8.3 Revenue

13.9 Seattle Genetics Inc

13.9.1 Overview
13.9.2 Recent Development
13.9.3 Revenue



List of Figures

Figure-01: Global – Cancer Immunotherapy Market (Billion US$), 2019 – 2023
Figure-02: Global – Forecast for Cancer Immunotherapy Market (Billion US$), 2024 – 2030
Figure-03: Products – Monoclonal Antibodies Market (Billion US$), 2019 – 2023
Figure-04: Products – Forecast for Monoclonal Antibodies Market (Billion US$), 2024 – 2030
Figure-05: Products – Immunomodulators Market (Billion US$), 2019 – 2023
Figure-06: Products – Forecast for Immunomodulators Market (Billion US$), 2024 – 2030
Figure-07: Products – Cancer Vaccines Market (Billion US$), 2019 – 2023
Figure-08: Products – Forecast for Cancer Vaccines Market (Billion US$), 2024 – 2030
Figure-09: Application – Lung Cancer Market (Billion US$), 2019 – 2023
Figure-10: Application – Forecast for Lung Cancer Market (Billion US$), 2024 – 2030
Figure-11: Application – Breast Cancer Market (Billion US$), 2019 – 2023
Figure-12: Application – Forecast for Breast Cancer Market (Billion US$), 2024 – 2030
Figure-13: Application – Colorectal Cancer Market (Billion US$), 2019 – 2023
Figure-14: Application – Forecast for Colorectal Cancer Market (Billion US$), 2024 – 2030
Figure-15: Application – Melanoma Market (Billion US$), 2019 – 2023
Figure-16: Application – Forecast for Melanoma Market (Billion US$), 2024 – 2030
Figure-17: Application – Prostate Cancer Market (Billion US$), 2019 – 2023
Figure-18: Application – Forecast for Prostate Cancer Market (Billion US$), 2024 – 2030
Figure-19: Application – Head & Neck Cancer Market (Billion US$), 2019 – 2023
Figure-20: Application – Forecast for Head & Neck Cancer Market (Billion US$), 2024 – 2030
Figure-21: Application – Others Market (Billion US$), 2019 – 2023
Figure-22: Application – Forecast for Others Market (Billion US$), 2024 – 2030
Figure-23: End Users – Hospital Market (Billion US$), 2019 – 2023
Figure-24: End Users – Forecast for Hospital Market (Billion US$), 2024 – 2030
Figure-25: End Users – Cancer Research Center Market (Billion US$), 2019 – 2023
Figure-26: End Users – Forecast for Cancer Research Center Market (Billion US$), 2024 – 2030
Figure-27: End Users – Clinics Market (Billion US$), 2019 – 2023
Figure-28: End Users – Forecast for Clinics Market (Billion US$), 2024 – 2030
Figure-29: United States – Cancer Immunotherapy Market (Billion US$), 2019 – 2023
Figure-30: United States – Forecast for Cancer Immunotherapy Market (Billion US$), 2024 – 2030
Figure-31: Canada – Cancer Immunotherapy Market (Million US$), 2019 – 2023
Figure-32: Canada – Forecast for Cancer Immunotherapy Market (Million US$), 2024 – 2030
Figure-33: Germany – Cancer Immunotherapy Market (Million US$), 2019 – 2023
Figure-34: Germany – Forecast for Cancer Immunotherapy Market (Million US$), 2024 – 2030
Figure-35: United Kingdom – Cancer Immunotherapy Market (Million US$), 2019 – 2023
Figure-36: United Kingdom – Forecast for Cancer Immunotherapy Market (Million US$), 2024 – 2030
Figure-37: France – Cancer Immunotherapy Market (Million US$), 2019 – 2023
Figure-38: France – Forecast for Cancer Immunotherapy Market (Million US$), 2024 – 2030
Figure-39: Italy – Cancer Immunotherapy Market (Million US$), 2019 – 2023
Figure-40: Italy – Forecast for Cancer Immunotherapy Market (Million US$), 2024 – 2030
Figure-41: Spain – Cancer Immunotherapy Market (Million US$), 2019 – 2023
Figure-42: Spain – Forecast for Cancer Immunotherapy Market (Million US$), 2024 – 2030
Figure-43: Switzerland – Cancer Immunotherapy Market (Million US$), 2019 – 2023
Figure-44: Switzerland – Forecast for Cancer Immunotherapy Market (Million US$), 2024 – 2030
Figure-45: Japan – Cancer Immunotherapy Market (Million US$), 2019 – 2023
Figure-46: Japan – Forecast for Cancer Immunotherapy Market (Million US$), 2024 – 2030
Figure-47: China – Cancer Immunotherapy Market (Million US$), 2019 – 2023
Figure-48: China – Forecast for Cancer Immunotherapy Market (Million US$), 2024 – 2030
Figure-49: India – Cancer Immunotherapy Market (Million US$), 2019 – 2023
Figure-50: India – Forecast for Cancer Immunotherapy Market (Million US$), 2024 – 2030
Figure-51: Australia – Cancer Immunotherapy Market (Million US$), 2019 – 2023
Figure-52: Australia – Forecast for Cancer Immunotherapy Market (Million US$), 2024 – 2030
Figure-53: South Korea – Cancer Immunotherapy Market (Million US$), 2019 – 2023
Figure-54: South Korea – Forecast for Cancer Immunotherapy Market (Million US$), 2024 – 2030
Figure-55: Indonesia – Cancer Immunotherapy Market (Million US$), 2019 – 2023
Figure-56: Indonesia – Forecast for Cancer Immunotherapy Market (Million US$), 2024 – 2030
Figure-57: Brazil – Cancer Immunotherapy Market (Million US$), 2019 – 2023
Figure-58: Brazil – Forecast for Cancer Immunotherapy Market (Million US$), 2024 – 2030
Figure-59: Argentina – Cancer Immunotherapy Market (Million US$), 2019 – 2023
Figure-60: Argentina – Forecast for Cancer Immunotherapy Market (Million US$), 2024 – 2030
Figure-61: Mexico – Cancer Immunotherapy Market (Million US$), 2019 – 2023
Figure-62: Mexico – Forecast for Cancer Immunotherapy Market (Million US$), 2024 – 2030
Figure-63: South Africa – Cancer Immunotherapy Market (Million US$), 2019 – 2023
Figure-64: South Africa – Forecast for Cancer Immunotherapy Market (Million US$), 2024 – 2030
Figure-65: Saudi Arabia – Cancer Immunotherapy Market (Million US$), 2019 – 2023
Figure-66: Saudi Arabia – Forecast for Cancer Immunotherapy Market (Million US$), 2024 – 2030
Figure-67: United Arab Emirates – Cancer Immunotherapy Market (Million US$), 2019 – 2023
Figure-68: United Arab Emirates – Forecast for Cancer Immunotherapy Market (Million US$), 2024 – 2030
Figure-69: Rest of World – Cancer Immunotherapy Market (Million US$), 2019 – 2023
Figure-70: Rest of World – Forecast for Cancer Immunotherapy Market (Million US$), 2024 – 2030
Figure-71: Amgen Inc. – Global Revenue (Million US$), 2019 – 2023
Figure-72: Amgen Inc. – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-73: AstraZeneca – Global Revenue (Million US$), 2019 – 2023
Figure-74: AstraZeneca – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-75: Bayer AG – Global Revenue (Million US$), 2019 – 2023
Figure-76: Bayer AG – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-77: Bristol-Myers Squibb Comapny – Global Revenue (Million US$), 2019 – 2023
Figure-78: Bristol-Myers Squibb Comapny – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-79: Pfizer Inc – Global Revenue (Million US$), 2019 – 2023
Figure-80: Pfizer Inc – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-81: Novarts AG – Global Revenue (Million US$), 2019 – 2023
Figure-82: Novarts AG – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-83: Johnson & Johnson – Global Revenue (Million US$), 2019 – 2023
Figure-84: Johnson & Johnson – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-85: Eli Lily Comapny – Global Revenue (Million US$), 2019 – 2023
Figure-86: Eli Lily Comapny – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-87: Seattle Genetics Inc – Global Revenue (Million US$), 2019 – 2023
Figure-88: Seattle Genetics Inc – Forecast for Global Revenue (Million US$), 2024 – 2030

List of Tables

Table-01: Global – Cancer Immunotherapy Market Share by Product (Percent), 2019 – 2023
Table-02: Global – Forecast for Cancer Immunotherapy Market Share by Product (Percent), 2024 – 2030
Table-03: Global – Cancer Immunotherapy Market Share by Application (Percent), 2019 – 2023
Table-04: Global – Forecast for Cancer Immunotherapy Market Share by Application (Percent), 2024 – 2030
Table-05: Global – Cancer Immunotherapy Market Share by End User (Percent), 2019 – 2023
Table-06: Global – Forecast for Cancer Immunotherapy Market Share by End User (Percent), 2024 – 2030
Table-07: Global – Cancer Immunotherapy Market Share by Countries (Percent), 2019 – 2023
Table-08: Global – Forecast for Cancer Immunotherapy Market Share by Countries (Percent), 2024 – 2030